Cynata Therapeutics Ltd
ASX:CYP

Watchlist Manager
Cynata Therapeutics Ltd Logo
Cynata Therapeutics Ltd
ASX:CYP
Watchlist
Price: 0.32 AUD Market Closed
Market Cap: 76m AUD

Profitability Summary

Cynata Therapeutics Ltd's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Cynata Therapeutics Ltd

Margins Comparison
Cynata Therapeutics Ltd Competitors

Country Company Market Cap Operating
Margin
Net
Margin
AU
Cynata Therapeutics Ltd
ASX:CYP
72.3m AUD
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
380.6B USD
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
182.4B USD
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
158.6B USD
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
116.5B USD
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.7B USD
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
85.3B AUD
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
42.5B EUR
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.5B USD
Loading...
Loading...
No Stocks Found

Return on Capital

Return on Capital Comparison
Cynata Therapeutics Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
AU
Cynata Therapeutics Ltd
ASX:CYP
72.3m AUD
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
380.6B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
182.4B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
158.6B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
116.5B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.7B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
85.3B AUD
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
42.5B EUR
Loading...
Loading...
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.5B USD
Loading...
Loading...
Loading...
Loading...
No Stocks Found

Free Cash Flow

Free Cash Flow Analysis
Cynata Therapeutics Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate